About Surrozen, Inc. 
Surrozen, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 3 Schemes (3.0%)
Foreign Institutions
Held by 3 Foreign Institutions (0.04%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
1 Million
(Quarterly Results - Jun 2025)
Net Profit:
22 Million
Pharmaceuticals & Biotechnology
USD 97 Million (Micro Cap)
6.00
NA
0.00%
-1.89
26.34%
2.07






